Mandate

Vinge has represented Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB

Vinge has represented the leading infrastructure group Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB from Vestum. These companies are engaged in contracting activities within the construction sector. The total purchase price for the shares amounts to 747 MSEK. All key executives in the companies will become shareholders in Eleda.

Hanell Entreprenad i Gävle AB and FlexiRail AB both have extensive experience in railway maintenance, and Eleda also strengthens its leading position in ground construction in Stockholm through the acquisition of Marbit Aktiebolag.

The transaction is subject to regulatory approvals, and the closing is expected to occur in the first quarter of 2025.

Vinge's team primarily consisted of Christina Kokko, Johanna Wiberg, Eléonore Friberg, Madelene Andersson, and Chris Bastholm (M&A), Niclas Lindblom (Construction), Sara Franson (Real Estate), Hanna Kövamees (Commercial Agreements), Siri Bromberg (GDPR), Calle Tengwall Pagels and William Carlberg Johansson (Banking and Finance), Simon Söderholm and Jessica Jacob (Employment Law), Hayaat Ibrahim and Gulestan Ali (Compliance), Marcus Glader, Daniel Wendelsson, Dagne Sabockis, Lovisa Lewin, and Lovisa Arpi (Competition Law and FDI), and Jasmina Skandrani (Project Assistant).

Read the client's press release here.

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).
October 03, 2025